Modified multivalent vaccine(CureVac)

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameModified multivalent vaccine(CureVac)

Drug Alias NameFlu-mRNA (Glaxosmithkline)FLU-SV-mRNA (Glaxosmithkline)GSK-4382276AGSK-4382276-AGSK-4382276

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumCanadaUnited States +[6]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc CureVac SE

China Registration ClassN/A

Develop Information

Active CompaniesCureVac SE Glaxosmithkline Plc

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A